US 7906530
1,7-naphthyridine derivatives as p38 MAP kinase inhibitors
granted A61PA61P1/00A61P11/00
Quick answer
US patent 7906530 (1,7-naphthyridine derivatives as p38 MAP kinase inhibitors) held by Laboratories Almirall, S.A. expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Laboratories Almirall, S.A.
- Grant date
- Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P11/00, A61P17/06, A61P19/04